Ledger.Open graph →
SEC Form D · filed August 11, 2025

Silexion Therapeutics Corp

Offering
$3.6M
Sold
$3.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RAMAT GAN, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Avner Lushi · Ramat Gan, L3DirectorMirit Horenshtein-Hadar · Ramat Gan, L3ExecAmnon Peled · Ramat Gan, L3DirectorMitchell Shirvan · Ramat Gan, L3ExecShlomo Noy · Ramat Gan, L3DirectorRuth Alon · Herzliya, L3DirectorIlan Levin · EDEN PRAIRIE, MNDirectorDror Abramov · Ramat Gan, L3DirectorIlan Hadar · TEL AVIV, L3Exec · DirectorMirit Horenshtein-Hadar · Ramat Gan, L3ExecAmnon Peled · Ramat Gan, L3DirectorMitchell Shirvan · Ramat Gan, L3ExecShlomo Noy · Ramat Gan, L3DirectorRuth Alon · Herzliya, L3DirectorIlan Levin · Ramat Gan, L3DirectorAvner Lushi · Ramat Gan, L3DirectorDror Abramov · Ramat Gan, L3DirectorIlan Hadar · TEL AVIV, L3Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗